UNION CITY, Calif., June 2 /PRNewswire-FirstCall/ —
Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced today that it will present at the
Jefferies 2010 Global Life Sciences Conference on Thursday, June 10, 2010 at The Grand Hyatt
Hotel in New York, New York. Don M. Bailey, President and Chief
Executive Officer, will discuss the Company’s business strategy and
historical financial performance at 11:30
a.m. Eastern Time.
Attendance at the conference is by invitation only. A live audio
Webcast of Questcor’s presentation may be accessed through the
Company’s website at www.questcor.com. An archived
replay of the presentation will be available after the live
presentation, and can also be accessed at www.questcor.com.
Questcor Pharmaceuticals, Inc. is a pharmaceutical company that
markets H.P. Acthar® Gel (repository corticotropin injection).
H.P. Acthar Gel (“Acthar”) is an injectable drug that is approved
for the treatment of certain disorders with an inflammatory
component, including the treatment of exacerbations associated with
multiple sclerosis (“MS”) and to induce a diuresis or a remission